Serum anti-mullerian hormone and all-cause mortality in men

被引:0
作者
Rehan Qayyum
Sana Akbar
机构
[1] University of Tennessee College of Medicine at Chattanooga,Department of Internal Medicine
[2] Johns Hopkins School of Medicine,Division of General Internal Medicine
来源
Endocrine | 2016年 / 54卷
关键词
Anti-mullerian hormone; Mortality; Men; NHANES;
D O I
暂无
中图分类号
学科分类号
摘要
Several studies have examined an association of anti-mullerian hormone to various risk factors for mortality, however, to the best of our knowledge, no study has reported a direct relationship between anti-mullerian hormone and all-cause mortality. Therefore, we examined the relationship between baseline anti-mullerian hormone levels and subsequent all-cause mortality in men during median follow-up of 9.4 (range = 0−13) years. We used the continuous National Health and Nutrition Examination Surveys from 1999–2004 combined with National Death Index for vital status information through December 2011. Cox proportional hazard models were fit to estimate hazard ratios for all-cause mortality. Models were adjusted for age, ethnic background, body mass index, hypertension, diabetes, smoking status, c-reactive protein, total cholesterol, estimated glomerular filtration rate, serum estradiol, testosterone, sex hormone binding globulin, and androstenedione. Of the 989 men, 30 % were older than 65 years, 51 % were Caucasians, 33 % had hypertension, 27 % were active smokers, and 11 % had diabetes. Mean serum anti-mullerian hormone level of the population was 7.2 (6.3) ng/mL. During the 8943 person-years of follow-up, 164 (17 %) men died. In unadjusted analysis, each unit increase in serum anti-mullerian hormone level was associated with a 13 % lower risk of death (HR = 0.87; 95 %CI = 0.83–0.92). In multivariable models, the inverse association between serum anti-mullerian hormone levels and mortality remained significant (HR = 0.94; 95 %CI = 0.90–0.98) and was independent of confounding variables. Similarly, individuals in the highest quartile had significantly lower risk of death as compared to individuals in the lowest quartile (unadjusted HR = 0.13, 95 %CI = 0.07–0.25; adjusted HR = 0.36, 95 %CI = 0.16–0.81). We found an independent and inverse association between serum anti-mullerian hormone levels and all-cause mortality in men. The mechanism underlying this association is unknown. Further studies are needed to validate our findings in men and to examine this association in women.
引用
收藏
页码:225 / 231
页数:6
相关论文
共 139 条
[1]  
Mullen RD(2014)Molecular genetics of Mullerian duct formation, regression and differentiation Sex Dev. 8 281-296
[2]  
Behringer RR(2013)Serum AMH in physiology and pathology of male gonads Int. J. Endocrinol. 2013 128907-238
[3]  
Matuszczak E(2011)Normal male sexual differentiation and aetiology of disorders of sex development Best Pract. Res. Clin. Endocrinol. Metab. 25 221-20
[4]  
Hermanowicz A(2015)Body mass index is associated with impaired semen characteristics and reduced levels of anti-mullerian hormone across a wide weight range PLoS One 10 e0130210-1359
[5]  
Komarowska M(2013)Serum anti-Mullerian hormone (AMH) levels correlate with infrarenal aortic diameter in healthy older men: is AMH a cardiovascular hormone? J. Endocrinol. 219 13-334
[6]  
Debek W(2012)Premenopausal antimullerian hormone concentration is associated with subsequent atherosclerosis Menopause 19 1353-2602
[7]  
Rey RA(2012)Anti-Mullerian hormone and inhibin B levels reflect altered Sertoli cell function in men with metabolic syndrome Andrologia 44 329-373
[8]  
Grinspon RP(2014)Prediagnostic circulating anti-Mullerian hormone concentrations are not associated with prostate cancer risk Cancer Epidemiol. Biomarkers Prev. 23 2597-612
[9]  
Andersen JM(2011)A multicentre evaluation of the new Beckman Coulter anti-Mullerian hormone immunoassay (AMH Gen II) Ann. Clin. Biochem. 48 370-634
[10]  
Herning H(2009)A new equation to estimate glomerular filtration rate Ann. Intern. Med. 150 604-112